domenica 15 giugno 2014

FDA Comes Out Against Aspirin To Prevent First Heart Attacks

In the latest development in a long-simmering debate, the FDA has announced that aspirin should not be marketed for the prevention of a first heart attack or stroke in people with no history of cardiovascular disease. The announcement follows FDA’s rejection on Friday of Bayer Healthcare’s decade-old  petition requesting approval of a [...]



FDA Comes Out Against Aspirin To Prevent First Heart Attacks

#FDA, #CardiovascularDisease, #LatestDevelopment

Nessun commento:

Posta un commento